Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    WuXi Biologics (Cayman) I...

    OTC: WXXWY · Real-Time Price · USD
    6.69
    -0.21 (-3.04%)
    At close: Jun 16, 2025, 3:59 PM

    WuXi Biologics (Cayman) Statistics

    Share Statistics

    WuXi Biologics (Cayman) has 2.1B shares outstanding. The number of shares has increased by 2.09% in one year.

    Shares Outstanding

    n/a
    		 2.1B

    Shares Change (YoY)

    n/a
    		 2.09%

    Shares Change (QoQ)

    n/a
    		 1.84%

    Owned by Institutions (%)

    n/a
    		 n/a

    Shares Floating

    n/a
    		 3.5B

    Failed to Deliver (FTD) Shares

    n/a
    		 1,499

    FTD / Avg. Volume

    n/a
    		 3.19%

    Short Selling Information

    The latest short interest is 178.93K, so 0% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 178.93K

    Short % of Shares Out

    n/a
    		 n/a

    Short % of Float

    n/a
    		 n/a

    Short Ratio (days to cover)

    n/a
    		 2.38

    Valuation Ratios

    The PE ratio is 20.73 and the forward PE ratio is 2.9. WuXi Biologics (Cayman)'s PEG ratio is 15.96.

    PE Ratio

    n/a
    		 20.73

    Forward PE

    n/a
    		 2.9

    PS Ratio

    n/a
    		 3.73

    Forward PS

    n/a
    		 0.5

    PB Ratio

    n/a
    		 1.66

    P/FCF Ratio

    n/a
    		 54.04

    PEG Ratio

    n/a
    		 15.96
    Financial Ratio History

    Enterprise Valuation

    WuXi Biologics (Cayman) has an Enterprise Value (EV) of 135.82B.

    EV / Sales

    n/a
    		 7.27

    EV / EBITDA

    n/a
    		 21.13

    EV / EBIT

    n/a
    		 26.03

    EV / FCF

    n/a
    		 105.48

    Financial Position

    The company has a current ratio of 2.73, with a Debt / Equity ratio of 0.12.

    Current Ratio

    n/a
    		 2.73

    Quick Ratio

    n/a
    		 2.56

    Debt / Equity

    n/a
    		 0.12

    Debt / EBITDA

    n/a
    		 0.77

    Debt / FCF

    n/a
    		 3.84

    Interest Coverage

    n/a
    		 31.56

    Financial Efficiency

    Return on Equity is 8.03% and Return on Invested Capital is 7.96%.

    Return on Equity

    n/a
    		 8.03%

    Return on Assets

    n/a
    		 5.89%

    Return on Invested Capital

    n/a
    		 7.96%

    Revenue Per Employee

    n/a
    		 $1,485,118.97

    Profits Per Employee

    n/a
    		 $266,885.17

    Employee Count

    n/a
    		 12,575

    Asset Turnover

    n/a
    		 0.33

    Inventory Turnover

    n/a
    		 7.25

    Taxes

    Income Tax

    n/a
    		 889.03M

    Effective Tax Rate

    n/a
    		 18.39%

    Stock Price Statistics

    The stock price has increased by 123% in the last 52 weeks. The beta is 0.55, so WuXi Biologics (Cayman)'s price volatility has been higher than the market average.

    Beta

    n/a
    		 0.55

    52-Week Price Change

    n/a
    		 123%

    50-Day Moving Average

    n/a
    		 5.9

    200-Day Moving Average

    n/a
    		 4.98

    Relative Strength Index (RSI)

    n/a
    		 57.44

    Average Volume (20 Days)

    n/a
    		 46,995

    Income Statement

    In the last 12 months, WuXi Biologics (Cayman) had revenue of 18.68B and earned 3.36B in profits. Earnings per share was 1.56.

    Revenue

    n/a
    		 18.68B

    Gross Profit

    n/a
    		 7.65B

    Operating Income

    n/a
    		 4.97B

    Net Income

    n/a
    		 3.36B

    EBITDA

    n/a
    		 6.43B

    EBIT

    n/a
    		 4.99B

    Earnings Per Share (EPS)

    n/a
    		 1.56
    Full Income Statement

    Balance Sheet

    The company has 8.28B in cash and 4.94B in debt, giving a net cash position of 3.34B.

    Cash & Cash Equivalents

    n/a
    		 8.28B

    Total Debt

    n/a
    		 4.94B

    Net Cash

    n/a
    		 3.34B

    Retained Earnings

    n/a
    		 16.36B

    Total Assets

    n/a
    		 56.98B

    Working Capital

    n/a
    		 14.95B
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was 5.22B and capital expenditures -3.93B, giving a free cash flow of 1.29B.

    Operating Cash Flow

    n/a
    		 5.22B

    Capital Expenditures

    n/a
    		 -3.93B

    Free Cash Flow

    n/a
    		 1.29B

    FCF Per Share

    n/a
    		 0.3
    Full Cash Flow Statement

    Margins

    Gross margin is 40.97%, with operating and profit margins of 26.63% and 17.97%.

    Gross Margin

    n/a
    		 40.97%

    Operating Margin

    n/a
    		 26.63%

    Pretax Margin

    n/a
    		 25.89%

    Profit Margin

    n/a
    		 17.97%

    EBITDA Margin

    n/a
    		 34.43%

    EBIT Margin

    n/a
    		 26.63%

    FCF Margin

    n/a
    		 6.89%

    Dividends & Yields

    WXXWY does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 4.82%

    FCF Yield

    n/a
    		 0.93%
    Dividend Details

    Analyst Forecast

    Currently there are no analyst rating for WXXWY.

    Price Target

    n/a
    		 n/a

    Price Target Difference

    n/a
    		 n/a

    Analyst Consensus

    n/a
    		 n/a

    Analyst Count

    n/a
    		 n/a
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 $19.73

    Lynch Upside

    n/a
    		 194.92%

    Graham Number

    n/a
    		 13.06

    Graham Upside

    n/a
    		 95.22%

    Stock Splits

    The last stock split was on Dec 10, 2020. It was a forward split with a ratio of 3:1.

    Last Split Date

    n/a
    		 Dec 10, 2020

    Split Type

    n/a
    		 forward

    Split Ratio

    n/a
    		 3:1

    Scores

    Altman Z-Score

    n/a
    		 2.43

    Piotroski F-Score

    n/a
    		 7

    Add to Watchlist